I can also remember how uplifted I felt, opening that bathroom door and feeling the cool morning air on my face. The world was crisp and new, I could see every leaf on every tree, and my third eye was fully open. It felt right. I didn’t know it at the time, but cannabis would become my remedy for what ails me for life.
In Minnesota, medical cannabis was approved for use in 2014. From July 2015 to February 2019, our center certified 103 pediatric and young adult patients for the use of medical cannabis under the qualifying conditions of cancer and treatment-related symptoms. Despite requesting certification, a subset (24%) never had medical cannabis dispensed. In our experience, pediatric and young adult oncology patients are interested in medical cannabis to help manage treatment-related symptoms. Ongoing analysis of this data will identify the therapeutic efficacy of medical cannabis.
Growing evidence suggests that medical marijuana laws have harm reduction effects across a variety of outcomes related to risky health behaviors. This study investigates the impact of medical marijuana laws on self-reported health using data from the Behavioral Risk Factor Surveillance System from 1993 to 2013. Subsample analyses reveal strong improvements in health among non-white individuals, those reporting chronic pain, and those with a high school degree, driven predominately by whether or not the state had active and legally protected dispensaries.
CBD or cannabidiol, a chemical compound of cannabis, is creating a wave of herbal revolution in the medical world. It has a promising ability to cure a wide array of diseases, both physical and psychological. The happy news is, some of the U.S states have legalized both recreational and medical cannabis, allowing the possibility for citizens to make the most out of the herb.
Tired of politicians dodging the debate on the legalization and normalization of cannabis in all its forms – from recreational and medical to the embrace of hemp as an alternative to manmade materials that harm the planet? Then perhaps it’s time for a Citizens’ Assembly…
Cancer cachexia (CC) is common in advanced cancer and is accompanied by negative effects on health-related quality of life (HRQOL). However, methods to identify the impact of CC on HRQOL are limited. Single questionnaire items may provide insight on the effect of CC on HRQOL. Specifically, the use of “feeling of wellbeing” (FWB) on the Edmonton Symptom Assessment System (ESAS) questionnaire and the Distress Thermometer (DT) have been explored. Future research should validate both multidimensional and single-item tools to measure HRQOL in patients at different stages of CC. Improvement of HRQOL via appetite stimulation, may be achieved through a multi-disciplinary approach, which includes cannabinoid therapy.
The endocannabinoid system is a complex and nearly ubiquitous network of endogenous ligands, enzymes, and receptors that can also be stimulated by exogenous compounds such as those derived from the marijuana plant, Cannabis sativa. This review seeks to summarize the current, and rapidly expanding field of research on the broad potential uses of cannabinoids in inflammatory and neoplastic diseases of the skin.
Tired of politicians dodging the debate on the legalization and normalization of cannabis in all its forms – from recreational and medical to the embrace of hemp as an alternative to manmade materials that harm the planet? Then perhaps it’s time for a Citizens’ Assembly…
A flowering plant of variegated ingredients and psychoactive qualities, Cannabis has long been used for medicinal and recreational purposes. Regulatory approvals have been gained across a broad range of palliative and therapeutic indications, and in some cases, included in standard treatment guidelines. Sufficient evidence supports the use of Cannabis for palliative indications in oncology; however, patients should be carefully selected, guided and followed. Promising research suggests the potent antineoplastic activity, but more data must be accrued before conclusions can be drawn.
According to an article from Business Insider, the marijuana business in the United States is a booming business. In fact, the industry saw $52 billion in sales in 2016 and experienced a 76% increase in cannabis jobs for 2019. It simply goes to show that the cannabis business is booming nationwide. The industry is estimated to have an impact of $77 billion to the US economy by 2022.